Molecular Profiling for Precision Oncology: Moving Beyond Feasibility and Safety

B Boris Freidlin (Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD) E Edward L. Korn (Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD) R Robert G. Maki (Memorial Sloan Kettering Cancer Center, New York, NY)

Article Details

Volume / Issue Vol. 44, Issue 7
Published March 01, 2026
Pages 515-517
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (3)

B

Boris Freidlin

Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD

E

Edward L. Korn

Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD

R

Robert G. Maki

Memorial Sloan Kettering Cancer Center, New York, NY